IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2023

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1,128,913$6,897,6580.03%
ARK Investment Management 808,966$4,942,7820.03%
ROANOKE ASSET MANAGEMENT CORP/ NY 12,800$780.03%
Dynamic Technology Lab Private Ltd 57,448$3510.03%
CIM INVESTMENT MANAGEMENT INC 13,773$84,1530.03%
E Fund Management Co., Ltd. 62,188$3800.03%
Hudson Bay Capital Management LP 987,106$6,031,2180.03%
Vident Investment Advisory, LLC 112,238$685,7740.02%
HRT FINANCIAL LP 267,997$1,6370.02%
TWO SIGMA ADVISERS, LP 1,244,200$7,602,0620.02%
GREAT LAKES ADVISORS, LLC 359,224$2,194,8600.02%
Cubist Systematic Strategies, LLC 496,979$3,036,5420.02%
Schonfeld Strategic Advisors LLC 302,518$1,848,3840.02%
PRELUDE CAPITAL MANAGEMENT, LLC 46,435$283,7180.02%
CREDIT SUISSE AG/ 2,696,842$16,477,7050.02%
D. E. Shaw & Co., Inc. 2,359,951$14,419,3010.02%
Renaissance Technologies 1,875,500$11,4590.02%
JUPITER ASSET MANAGEMENT LTD 164,360$1,002,5960.01%
CAPITAL FUND MANAGEMENT S.A. 435,246$2,659,3530.01%
MILLENNIUM MANAGEMENT LLC 3,412,599$20,8510.01%
External links

This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q1 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.